The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance.

Circ Cardiovasc Qual Outcomes

From the Lahey Hospital and Medical Center, Burlington, MA (A.K., T.C.P., S.R., F.S.R.); Tufts School of Medicine, Boston, MA (A.K., T.C.P., F.S.R.); VA Tennessee Valley Healthcare System and Vanderbilt University, Nashville (M.E.M.); Beth Israel Deaconess Medical Center, Boston, MA (K.K.L.H.); Harvard Medical School, Boston, MA (K.K.L.H., R.W.Y., H.W., P.B.S., S.-L.N.); Massachusetts General Hospital, Boston (R.W.Y.); North Shore Medical Center, Salem (H.W.); Brigham and Women's Hospital, Boston, MA (P.B.S., S.D.); Boston Advanced Analytics, Newton, MA (R.C.); and Harvard School of Public Health, Boston MA (S.-L.N.).

Published: January 2015

Background: Current approaches for postmarket medical device safety surveillance are limited in their ability to produce timely and accurate assessments of adverse event rates.

Methods And Results: The Data Extraction and Longitudinal Trend Analysis (DELTA) network study was a multicenter prospective observational study designed to evaluate the safety of devices used during percutaneous coronary interventions. All adult patients undergoing percutaneous coronary intervention from January 2008 to December 2012 at 5 participating Massachusetts sites were included. A safety alert was triggered if the cumulative observed adverse event rates for the study device exceeded the upper 95% confidence interval of the event rates of propensity-matched control cohort. Prespecified sensitivity analyses were developed to validate any identified safety signal. A total of 23,805 consecutive percutaneous coronary intervention procedures were evaluated. Two of 24 safety analyses triggered safety alerts. Patients receiving Perclose vascular closure device experienced an increased risk of minor vascular complications (relative risk, 4.14; P<0.01) and any vascular complication (relative risk, 2.06; P=0.01) when compared with propensity-matched patients receiving alternative vascular closure device, a result primarily driven by relatively high event rates at 1 participating center. Sensitivity analyses based on alternative risk adjustment methods confirmed a pattern of increased rate of complications at 1 of the 5 participating sites in their use of Perclose vascular closure device.

Conclusions: The DELTA network study demonstrates that distributed automated prospective safety surveillance has the potential of providing near real-time assessment of safety risks of newly approved medical devices.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130285PMC
http://dx.doi.org/10.1161/CIRCOUTCOMES.114.001123DOI Listing

Publication Analysis

Top Keywords

percutaneous coronary
12
data extraction
8
extraction longitudinal
8
longitudinal trend
8
trend analysis
8
network study
8
device safety
8
safety surveillance
8
adverse event
8
coronary intervention
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!